Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
Pediatric Vaccines: Global Markets
US$ 5,500.00
Report : This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market’s drivers, challenges and opportunities. The report also covers mark...
September 2022
110 pages
United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2028
US$ 2,699.00
Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. The prominent factors that a...
June 2022
215 pages
Influenza Vaccines: Global Markets
US$ 5,500.00
Report : The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakehold...
May 2022
109 pages
United States Influenza Vaccines Market: Focus on Persons Vaccinated, Pricing, Production, Supply, Promising Influenza Vaccines, Clinical Trials, Regulatory, Reimbursement, Distribution Channel, Major Deals, Key Players, Recent Developments – Size, Share, Trends, Analysis, Demand, Opportunity, and Forecast, 2022 – 2030
US$ 3,450.00
The United States Influenza Vaccines market size is expected to reach USD 7,007 million by 2030. It is expected to expand at a CAGR of 6.9% from 2021 to 2030. This new market report offerings an wide-...
February 2022
220 pages
Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccines), Valence (Multivalent, Monovalent) - Global Forecast to 2028
US$ 4,175.00
Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccin...
November 2021
229 pages
DNA Vaccines: Technologies and Global Markets
US$ 5,500.00
Report : The study’s scope includes DNA vaccine products that already are commercialized or likely to be in the next five years. Both human and animal health markets are studied. DNA vaccine delivery...
August 2021
113 pages
Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2027
US$ 2,590.00
The global influenza vaccines market is projected to exceed US$ 9.5 Billion mark by 2027, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major c...
July 2021
322 pages
Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027
US$ 3,750.00
Global Vaccine Adjuvants Market is valued approximately at USD 0.70 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2021-2027. Vaccine...
July 2021
200 pages
Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026
US$ 4,500.00
Global coronavirus vaccine market is expected to grow at a robust rate in value terms to reach USD91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronavirid...
July 2021
119 pages
Global Neoantigen Cancer Vaccine Market, By Product (Personalized Neoantigen Vaccine, Off-the Shelf Neoantigen Vaccine), By Neoantigen Type (Synthetic Long Peptide (SLP), Nucleic Acid, Dendritic Cell, Tumor Cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Electroporation, Gene gun, Others), By Application (Lung, Melanoma, Gastrointestinal, Brain Cancer, Others), By Region, Competition, Forecast & Opportunities, 2026
US$ 4,500.00
Global neoantigen cancer vaccine market is projected to grow with a CAGR of 54.18% during the forecast period and is expected to reach USD1754.44 million by 2026. The key factors responsible for the g...
July 2021
284 pages
Vaccine Delivery Devices: Global Markets
US$ 5,500.00
Report This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery...
June 2021
141 pages
Global Companion Animal Vaccine Market Size study, by Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Technologies), by Animal Type (Dogs, Cats, Other Animal Types ), and Regional Forecasts 2021-2027
US$ 3,750.00
Global Companion Animal Vaccine Market is valued at approximately USD 8.0 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.2 % over the forecast period 2021-2027. T...
May 2021
200 pages
Vaccine Market in India 2020 – Focus on COVID-19
US$ 950.00
Market insights In the past decade, the demand for vaccines has surged in India, fuelled by increased awareness of health and hygiene. Furthermore, support extended by the Indian government to enhance...
October 2020
93 pages
United States Pediatric Vaccines Market 2020 – 2027
US$ 1,990.00
The United States pediatric vaccines market is projected to exceed US$ 15 Billion by 2027. Growth in the United States pediatric vaccine market can be accredited to factors such as, increasing communi...
September 2020
120 pages
Global Animal Vaccine Market, By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others), By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others), By Disease (Foot and mouth diseases, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others), By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies), By Region, Competition, Forecast & Opportunities, 2025
US$ 4,500.00
Global animal vaccine market is forecast to grow from an estimated $ 6.3 billion in 2019 to $ 8.1 billion by 2025. Rising meat consumption is a major factor driving the market. Another factor which dr...
September 2020
125 pages
Global DNA Vaccine Market Outlook 2022
US$ 1,800.00
... immune response. This comprehensive report by RNCOS entitled “Global DNA Vaccine Market Outlook 2022” provides an in-depth analysis of the global DNA Vaccines market, presenting readers a profound understanding of the various ...
June 2020
100 pages
Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020
US$ 1,290.00
“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market. The report offers the most u...
April 2020
135 pages
Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies
US$ 1,390.00
“Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Compani...
April 2020
165 pages
Global Dengue Vaccines Market Outlook 2027
US$ 4,150.00
Global Dengue Vaccine Market Analysis – 2018-2027 Dengue (also known as dengue fever) is a viral disease in humans transmitted by the mosquitoes of genus Aedes, and are divided into four serotypes, wh...
March 2020
60 pages
United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026
US$ 2,190.00
The United States vaccines market is poised to reach a value of more than US$ 26 billion by 2026. “United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and...
November 2019
150 pages
Global Conjugate Vaccines Market (2017 - 2022)
US$ 2,950.00
... order is placed. The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of ... diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such ...
November 2019
90 pages
